UWM
FBIO icon

Urban Wealth Management’s Fortress Biotech FBIO Stock Holding History

Urban Wealth Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$6K Buy
+509
New +$7.54K 0.02% 231

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Urban Wealth Management's FBIO Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Fortress Biotech (FBIO) in Q2 2022: 509 shares worth $6K. The stake represents 0.02% of the portfolio and ranks #231 among its holdings.

66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

  • Urban Wealth Management held 509 shares of Fortress Biotech worth $6K as of Q2 2022.
  • Fortress Biotech was a new Urban Wealth Management position in Q2 2022.
  • Fortress Biotech made up 0.02% of Urban Wealth Management's portfolio in Q2 2022, its #231 holding.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.